U.S Department of Health & Human ServicesHHSNational Institutes of HealthNIHNCATSNCATSCTSA ProgramCTSA
CTSA CCOS

Coordination, Communication, and Operations Support

RegisterLog In
Home
Home
Need Help

CTSA Groups and Meetings

CTSA Program groups and committees execute the recommendations of the NCATS Advisory Council Working Group and encourage collaboration within the CTSA Program. The objectives of each group and committee include meeting both short- and long-term needs to provide patients with access to treatments more quickly through translational science, providing a structure where measurable objectives can support the strategic goals of the CTSA Program, advocating for inclusivity by allowing all CTSA Hubs and their members to have equal access to resources, and fostering a collaborative group dynamic with discrete objectives, timelines, and deliverables for each activity. Learn about the different types of groups and committees below.

Steering Committee

The Steering Committee serves as a forum where CTSA Program Principal Investigators (PIs), Administrators, and NCATS leadership can collaborate, share insights, and provide feedback to enhance the CTSA Program and promote progress in the field of clinical and translational science.
Learn More
Pods

Enterprise Committees

Enterprise Committees play a vital role in advancing clinical and translational science by focusing on high-priority areas as designated by NCATS. These committees engage in a range of activities to achieve CTSA Program objectives, including promoting collaboration and innovation, creating a space for discussion, and disseminating best practices. In addition to these activities, the Enterprise Committees may develop plans for projects that fill gaps and further program objectives.
Learn More
Committees
Diversity, Equity, Inclusion and AccessibilityInformaticsCollaboration & Engagement Integration Across the LifespanWorkforce Development
Enterprise Committees

Working Groups

Working Groups are designed to address specific clinical and translational science issues. The members of each working group are responsible for proposing and delivering well-defined deliverables that fill identified translational science gaps and further the CTSA Program objectives in high priority areas. CCOS provides simultaneous support for up to 12 active working groups.
Learn More
Active Groups
CTSA Pharmacies and Compounding for Translational ResearchIntegrating CTS into the Virtual CTSA Visiting Scholar Program21 CFR Part 11 Compliance for REDCapAdvancing Dissemination and Implementation SciencesEngaging Individuals with Disability in the Research Process TL1 Visiting Scientist Translational Science Competency-Based Assessment Translational Science Case StudiesHarnessing Innovation and Engagement
Consortium Groups

Consortium Groups

The Consortium Groups bring together individuals with specialized skills and experience from different CTSA hubs to collaborate and share insights across the consortium. These groups include Communicators, Administrators, KL2/K12 PI Directors, and TL1/T32 PI Directors.
Learn More
Groups

Discussion Forums

The NCATS CTSA Program Steering committee provides leadership for sharing of policies, practices and resources, and discussion of opportunities, impediments, joint agreement on broad issues impeding clinical research and other appropriate topics.

Upcoming Meetings

Consortium Groups and Committees meet regularly to work towards achieving the goals of the CTSA Program.   

 

 

View Archive
A purple calendar icon

Upcoming Meetings

Consortium Groups and Committees meet regularly to work towards achieving the goals of the CTSA Program.   

 

 

View Archive
A purple calendar icon

General FAQs

Please refer below to the most frequently asked questions. To learn about each group/committee in detail, please visit its specific page, or sign into the portal to view more FAQs.

Enterprise Committees are groups that focus on high priority areas in clinical and translational science, with the aim of advancing CTSA Program objectives.

Enterprise Committees may propose any number of Working Groups, but the Steering Committee can approve a maximum of 12 Working Groups at any time. The Steering Committee also supports and approves Working Groups in all areas of clinical and translational science, with a limit of two Working Groups from any specific Enterprise Committee.

Working Groups are one way that Enterprise Committees can carry out projects to achieve program objectives and fill identified gaps.

Each CTSA Program hub is required to have membership of at least one Enterprise Committee.

The Steering Committee Co-chair must be nominated by themselves or others to be on the lead team of the Enterprise Committee and go through the election process. The Enterprise Committee lead team can choose to make them the chair or co-chair of the EC, but they will not serve as a Steering Committee member for any Working Groups originating from their Enterprise Committee due to conflict of interest.

The incoming lead team for the Enterprise Committee will decide who will be the chair or co-chair for the coming year.

Please refer to the CTSA Program Groups Guidance document for clarification.

No, each hub can only have one voting member on an Enterprise Committee.

Enterprise Committees report annually to the Steering Committee via a teleconference meeting. Enterprise Committees will report annually to the Consortium through a CTSA Program Webinar and hold an annual face-to-face meeting.

Working Groups are groups that focus on developing solutions for specific clinical and translational science issues. They propose and deliver well-defined projects or deliverables that fill identified translational gaps and/or further the CTSA Program objectives in high priority areas in clinical and translational science.

Anyone in the CTSA Program and a limited number of community members (See CTSA Program Groups Guidance document.)

Most members of the CTSA Program want to propose and deliver well-defined projects or deliverables that fill identified translational gaps and/or further the CTSA Program objectives in high priority areas in clinical and translational science. For example, Working Group proposals may be submitted by DF members, hub or pod members, or consortium committees. CD2H and TIN are not allowed to propose WGs through this process, as they have other available resources.

The maximum timeframe is 2 years. Requests for additional time require Steering Committee review and may result in transition to a discussion forum.

All content will be archived, and requests may be made to access the information.

Coordination, Communication, and Operations Support (CCOS) is funded by theNational Center for Advancing Translational Sciences, National Institutes of Health.

HomeContact UsPrivacy PolicyAccessiblity Statement
Freedom of Information (FOIA)Office of Inspector General (OIG)Cookie Preference
twitter iconlinkedin icon